Plain-English translation of NCT06595992 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This is a long-term tracking study for people diagnosed with moderate aortic valve disease — a condition where the aortic valve (the valve that controls blood flow out of your heart) is damaged but not yet severely. The researchers want to follow you over time with regular heart ultrasounds and tests to understand how your condition might progress and what warning signs show up before it gets worse.
Right now, doctors don't have clear guidance on how to best monitor and manage moderate aortic valve disease, and it's hard to predict which patients will get worse and when. This study aims to identify early warning signs and risk factors so that future treatments can help prevent serious complications and improve survival.
You likely qualify if…
You likely don't qualify if…
You will visit the hospital clinic once per year for follow-up appointments. At each visit, you'll have a heart ultrasound (echocardiogram) and possibly a CT scan, along with blood tests and discussions about your symptoms and medical history. The study will continue to monitor your condition over time to see how it changes and what factors influence disease progression.
AI-generated summary from trial data · Jun 2, 2026 · Not medical advice
China
Sponsor
Second Affiliated Hospital, School of Medicine, Zhejiang University
Enrollment target
~1,000 participants
Started
September 2024
Primary completion
January 2034
Age range
18 Years and older
Last updated on clinicaltrials.gov in September 2024.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Xianbao Liu, Dorctor
Second Affiliated Hospital of Zhejiang University, School of Medicine
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.